SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 102,400
+3,200 (3.23%)
At close: May 14, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.77 trillion as of May 14, 2026. Its market cap has decreased by -3.31% in one year.
Market Cap
7.77T
Enterprise Value
7.52T
Revenue
706.74B
Ranking
n/a
PE Ratio
29.10
Stock Price
102,400.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.77T, a decrease of -21.89%. That is a compound annual growth rate of -4.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 8.02T | -17.82% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 17.39T |
| Samsung Epis Holdings | 12.94T |
| Kolon TissueGene | 11.26T |
| HLB Co., Ltd. | 7.52T |
| LigaChem Biosciences | 7.50T |
| Peptron | 6.68T |
| Voronoi | 4.93T |
| OliX Pharmaceuticals | 3.40T |